Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial

20041,165 citationsJournal Article

Authors

E. William St. Clair · Duke Medical Center

Désirée van der Heijde · Maastricht University Medical Centre

Josef S Smolen · Medical University of Vienna

Ravinder N. Maini · British Society for Rheumatology

Joan M. Bathon · Johns Hopkins University

Paul Emery · University of Leeds

Edward Keystone

Abstract

For patients with active RA in its early stages, combination therapy with MTX and infliximab provides greater clinical, radiographic, and functional benefits than treatment with MTX alone.

Topics & Keywords

Rheumatoid Arthritis Research and Therapies Chronic Lymphocytic Leukemia Research Autoimmune and Inflammatory Disorders Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Arthritis & Rheumatism

Volume 50, Issue 11, pp. 3432-3443

DOI: 10.1002/art.20568

Field-Weighted Citation Impact: 53.45